You are viewing Asia Pacific

FloraGLO® Lutein for Eye Health

floraglo_banner1_small

FloraGLO® Lutein is a high-quality, naturally-sourced lutein known for its effectiveness in supporting eye health, particularly in protecting against harmful blue light.1

Key Benefits:

Blue Light Protection:

  • Absorbs harmful blue light, reducing eye strain and protecting against potential damage from digital screens and artificial lighting.1

Age-Specific Support:2-5

  • Aging Adults: Helps protect aging eyes from the effects of blue light.
  • Infants and Children: Supports the development of children's eyes by reducing damage from blue light exposure.

Features:

  • Derived from marigold flowers.
  • Backed by extensive clinical research, including studies like the Age-Related Eye Disease Study 2 (AREDS2).6
  • Trusted by healthcare professionals worldwide for its proven benefits in maintaining healthy vision.7

FloraGLO Benefits to the Eyes

 

 

 

 


Resources

Enhancing Eye Health

Targeting Visual Performance

Protecting Eye Health in a Digital World

FloraGLO® Lutein: So Much More Than An "Eye Vitamin"

Navigating Women's Health Paradoxes


Want to learn more about FloraGLO?

If you're interested in formulating with FloraGLO Lutein, fill out the form below and a Kemin representative will be in touch shortly.

Recommended use: a dose of = 10 mg FloraGLO® Lutein and 2 mg OPTISHARP™ Natural Zeaxanthin is considered efficacious.

*Kemin has a blue light patent covering three conditions for people of all ages; presbyopia, hyperopia, and astigmatism.

OPTISHARP™ Natural is a Registered Trademark of DSM Nutritional Products Ltd.

OPTISHARP™ Natural is made with ZeaOne(R) from KEMIN. ZeaOne is a [registered] trademark of KEMIN Industries, Inc. 

These statements have not been evaluated by the US Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.

The information on this webpage is a business-to-business information and not intended for the final consumer. Certain statements may not be applicable in all geographical regions. Product labeling and associated claims differs based upon government requirements and country or region specific information should also be considered when labeling or advertising to final consumers.

This web page and its associated brochures and other documents do not constitute or provide scientific or medical advice, diagnosis, or treatment and are distributed without warranty of any kind, either expressly or implied. This web page, its title or contents and associated brochures and other documents do not in any way make recommendations for health or marketing claims by the reader. Country and region specific regulations should be considered in this regard. Each claim or statement about the effectiveness of Kemin products and/or each claim or statement comparing the effectiveness of Kemin products to the effectiveness of other products is expressly limited to the United States, unless otherwise disclosed on the Kemin websites.

References:

  1. Roberts, Richard. “Methods of Treating Ocular Disorders.” Kemin Industries, Inc., assignee. Patent US9226940 B2. Jan. 2016. Kemin's patent covers three conditions for all ages; presbyopia, hyperopia, and astigmatism.
  2. Lai et al., Nutrients. 2020;12(2):1–11).
  3. Hammond BR. Nutr Rev. 66(12):695-702, 2008.
  4. Berstein Invest Ophthalmol Vis Sci. 2013 Jun 10;54(6):4034-40.
  5. Stringham, J. M. & Hammond, B. R. Macular pigment and visual performance under glare conditions. Optom. Vis. Sci. Off. Publ. Am. Acad. Optom. 85, 82–88 (2008).
  6. PubMed, 2021.
  7. Based on the results of the IQVIA IMS National Disease and Therapeutic Index (NDTI) syndicated report among physicians who recommend a dietary supplement with lutein for eye health through between June 1, 2017 to May 31, 2018.